10
podcast episode
Ep. 49: Time Equals Lives, with FasterCures’ Esther Krofah
“We spend numerous hours a day updating that tracker because what is critical is real-time informa
tion that researchers and scientists can respond to....As I've been speaking to colleagues, ranging from NIH to these large companies, they're usin
+ Read More
article
FasterCures Quarterly Update—July 2024
In This Newsletter
Highlights from Global Conference
Recent Publications
Policy Updates
FasterCures
Program Updates
+ Read More
podcast episode
Ep. 50: Special Edition — Potential Breakthroughs in COVID-19 Research Coming From Cancer Research
For our 50th recording, Jonathan Simons (President and CEO, Prostate Cancer Foundation) and Esther
Krofah (Executive Director, FasterCures) join Mike for a special discussion on how breakthroughs in cancer laboratories are advancing our understa
+ Read More
video
How COVID-19 Tests Will Help Reopen America - Conference Call Series
There is widespread recognition that our ability to efficiently perform testing for COVID-19 on a
large scale—whether to diagnose current cases or determine who might have immunity—is key to restarting economic activity in the US.
+ Read More
video
Ep. 50: Special Edition - Potential Breakthroughs in COVID-19 Research Coming From Cancer Research
For our 50th recording, Jonathan Simons (President and CEO, Prostate Cancer Foundation) and Esther
Krofah (Executive Director, FasterCures) join Mike for a special discussion on how breakthroughs in cancer laboratories are advancing our understanding an
+ Read More
article
TRAIN Newsletter — July 2024
TRAIN eNews is delivered directly to organizations that take part in The Research Acceleration and I
nnovation Network (TRAIN).
+ Read More
article
Milken Institute COVID-19 tracker update identifies more than 100 vaccines and nearly 200 treatments in development
Nine vaccines and more than 50 treatment candidates currently in clinical trials.
article
An Update from MI Health—July 2024
In This Issue:
article
Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials
The Milken Institute celebrates the publication of the second iteration of the Food and Drug Adminis
tration (FDA) draft guidance on Diversity Action Plans (DAP) to improve clinical trial diversity by enrolling underrepresented populations in the US.
+ Read More
article
How COVID-19 Tests Will Help Reopen America
.bubble-images, .bubble-images img {
border-radius: 50%;
}
How COVID-19 Tests Will Help Reopen Ame
rica
Tuesday, May 19 | 8 am PT
+ Read More